Spectrum Fertility Group

Spectrum Fertility Genomics is a leading provider of cutting-edge solutions for In Vitro Fertilization (IVF) and reproductive genomics. The company specializes in epigenomic innovation and genetic analysis tools designed to support fertility clinics, reproductive laboratories, and healthcare professionals. Their product portfolio includes preimplantation genetic diagnostic (PGD) kits and DNA methylation detection assays used in IVF embryo screening and selection. The company positions itself as a trusted partner for assisted reproductive technology (ART) providers, offering molecular diagnostic solutions that help improve fertility outcomes by enabling genomic profiling of embryos prior to implantation. Spectrum Fertility Genomics maintains strategic partnerships with international life science companies and actively participates in professional conferences including the American Society for Reproductive Medicine (ASRM) and the Preimplantation Genetic Diagnosis International Society (PGDIS), indicating alignment with clinical and regulatory standards in the reproductive medicine field.